HR Execs on the Move

New York Genome Center

www.nygenome.org

 
The New York Genome Center (NYGC) is at the forefront of transforming biomedical research and clinical care with the mission of saving lives. As a consortium of renowned academic, medical and industry leaders across the globe, NYGC focuses on translating genomic research into clinical solutions for serious disease. Our member organizations are united in this unprecedented collaboration of technology, science, and medicine. We implement advanced genomic research, and integrate our findings with world-class technologies and physician-scientists in order to help solve diseases. We harness the diversity of New York`s institutions and people to drive scientific discoveries that will vastly improve clinical ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.nygenome.org
  • 101 Avenue of the Americas
    New York, NY USA 10013
  • Phone: 646.977.7000

Executives

Name Title Contact Details

Similar Companies

American Academy Of Pain Medicine

American Academy Of Pain Medicine is a Glenview, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Angeion Corporation

Angeion Corporation is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Bionor Pharma

Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.

Liberty HealthShare

Liberty HealthShare is a group of self pay patients who freely share each others` medical expenses on a voluntary, cooperative basis. Liberty HealthShare is not insurance. We simply unite like minded Americans to share medical expenses together. Our mission is to make the Christian tradition of healthcare sharing available and affordable to all.

APAC Partners

APAC Partners is a Dyer, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.